NCF Partner, ALS Association (Amyotrophic lateral sclerosis, also known as Lou
Gehrig's Disease) was in the news regarding stem cell's production and the use in ALS. Working with BioFocus DPI, a UK group, ALS Association will send batches of stem cells for their research services. The article explains what stem cells could do for people with ALS: "Embryonic stem cells offer the hope of providing an unlimited supply of living human cells for use in drug discovery and cell transplant therapy. The hard part is coaxing stem cells to turn into the various types of cells that are needed for research--muscle, bone, neuron, liver cell pancreas and so on."

From the article:
Until now, Estess notes, researchers have had to test their experimental ALS drugs on mice that have been genetically engineered to get the disease. Too often, the drugs work great in the mice and then "failed miserably in people," she says. "What stem cells will provide us in the very short term is much better disease models. They will allow us to screen drugs more effectively … and will represent human disease more accurately."